Hepatic cytoprotective effect of ischemic and anesthetic preconditioning before liver resection when using intermittent vascular inflow occlusion: A randomized clinical trial

Surgery (United States)

Volumn 157, Issue 2, 2015, Pages 249-259

  Rodríguez, Aurora ^a   Taurà, Pilar ^b   García Domingo, Maria I ^a   Herrero, Eric ^a   Camps, Judith ^a   Forcada, Pilar ^a   Sabaté, Sergi ^c   Cugat, Esteve ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c FUNDACIÓ PUIGVERT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRACURIUM BESILATE; BILIRUBIN; BIOLOGICAL MARKER; CASPASE 3; FENTANYL; HEMOGLOBIN; HYALURONIC ACID; PROPOFOL; REMIFENTANIL; SEVOFLURANE; CASP3 PROTEIN, HUMAN; ETHER DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; INHALATION ANESTHETIC AGENT; MESSENGER RNA; NOS2 PROTEIN, HUMAN;

ADJUVANT CHEMOTHERAPY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL PROTECTION; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EVALUATION STUDY; FATTY LIVER; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTENSIVE CARE; INTERMITTENT CLAMPING; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC PRECONDITIONING; LENGTH OF STAY; LEUKOCYTE; LIVER CELL; LIVER CONGESTION; LIVER FUNCTION; LIVER HISTOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; LIVER RESECTION; LIVER SINUSOID; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REPERFUSION INJURY; SURGICAL MORTALITY; ADVERSE EFFECTS; AGED; GENETICS; INJURIES; LIVER; LIVER FUNCTION TEST; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, INHALATION; CASPASE 3; FEMALE; HEPATECTOMY; HUMANS; ISCHEMIC PRECONDITIONING; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; METHYL ETHERS; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84921377597     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2014.09.005     Document Type: Article

References (39)

1. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309 321
2. V.P. Khatri, N.J. Petrelli, and J. Belghiti Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23 2005 8490 8499
3. C.B. Rosen, D.M. Nagorney, H.F. Taswell, S.L. Helgeson, D.M. Ilstrup, and J.A. van Heerden Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma Ann Surg 216 1992 493 505
4. N.N. Rahbari, C. Reissfelder, M. Koch, H. Elbers, F. Striebel, and M.W. Buchler The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients Ann Surg Oncol 18 2011 3640 3649
5. J.H. Pringle Notes on the arrest of hepatic hemorrhage due to trauma Ann Surg 48 1908 541 549
6. J.A. Melendez, V. Arslan, M.E. Fischer, D. Wuest, W.R. Jarnagin, and Y. Fong Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction J Am Coll Surg 187 1998 620 625
7. Y. Zhai, R.W. Busuttil, and J.W. Kupiec-Weglinski Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation Am J Transplant 11 2011 1563 1569
8. F. Serracino-Inglott, N.A. Habib, and R.T. Mathie Hepatic ischemia-reperfusion injury Am J Surg 181 2001 160 166
9. N. Selzner, H. Rudiger, R. Graf, and P.A. Clavien Protective strategies against ischemic injury of the liver Gastroenterology 125 2003 917 936
10. P.A. Clavien, S. Yadav, D. Sindram, and R.C. Bentley Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans Ann Surg 232 2000 155 162
11. M. Massip-Salcedo, J. Roselló-Catafau, J. Prieto, M.A. Avíla, and C. Peralta The response of the hepatocyte to ischemia Liver Int 27 2007 6 16
12. J. Belghiti, R. Noun, R. Malafosse, P. Jagot, A. Sauvanet, and F. Pierangeli Continuous versus intermittent portal triad clamping for liver resection: a controlled study Ann Surg 229 1999 369 375
13. H. Petrowsky, L. McCormack, M. Trujillo, M. Selzner, W. Jochum, and P.A. Clavien A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection Ann Surg 244 2006 921 930
14. C. Peralta, G. Hotter, D. Closa, N. Prats, C. Xaus, and E. Gelpí The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors Hepatology 29 1999 126 132
15. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
16. M. Wakeno-Takahashi, H. Otani, S. Nakao, Y. Uchiyama, H. Imamura, and K. Shingu Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and -independent mechanisms Anesthesiology 100 2004 515 524
17. O. Heizmann, G. Meimarakis, A. Volk, D. Matz, D. Oertli, and R.J. Schauer Ischemic preconditioning-induced hyperperfusion correlates with hepatoprotection after liver resection World J Gastroenterol 16 2010 1871 1878
18. B. Beck-Schimmer, S. Breitenstein, S. Urech, E. De Conno, M. Wittlinger, and M. Puhan A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic Ann Surg 248 2008 909 918
19. S.M. Strasberg Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system J Hepatobiliary Pancreat Surg 12 2005 351 355
20. P.A. Clavien, M. Selzner, H.A. Rudiger, R. Graf, Z. Kadry, and V. Rousson A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning Ann Surg 238 2003 842 843
21. S.G. De Hert, P.J. Van der Linden, S. Cromheecke, R. Meeus, A. Nelis, and V. Van Reeth Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration Anesthesiology 101 2004 299 310
22. G. Garcea, S.L. Ong, and G.J. Maddern Predicting liver failure following major hepatectomy Dig Liver Dis 41 2009 798 806
23. H.A. Rüdiger, R. Graf, and P.-A. Clavien Liver ischemia: apoptosis as a central mechanism of injury J Invest Surg 16 2003 149 159
24. A. Bressenot, S. Marchal, L. Bezdetnaya, J. Garrier, F. Guillemin, and F. Plénat Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma J Histochem Cytochem 57 2009 289 300
25. P.A. Clavien, J. Barkun, M.L. de Oliveira, J.N. Vauthey, D. Dindo, and R.D. Schulick The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
26. N.N. Rahbari, O.J. Garden, R. Padbury, M. Brooke-Smith, M. Crawford, and R. Adam Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS) Surgery 149 2011 713 724
27. A. Hannes, K.-J. Kang, and D. Sindram Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver Ann Surg 235 2002 400 407
28. K.S. Gurusamy, Y. Kumar, V. Pamecha, D. Sharma, and B.R. Davidson Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion Cochrane Database Syst Rev 2009 CD007629
29. A. Choukèr, A. Martignoni, R. Schauer, M. Dugas, H.-G. Rau, and K.-W. Jauch Beneficial effects of ischemic preconditioning in patients undergoing hepatectomy: the role of neutrophils Arch Surg 140 2005 129 136
30. V. Smyrniotis, K. Theodoraki, N. Arkadopoulos, G. Fragulidis, A. Condi-Pafiti, and M. Plemenou-Fragou Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study Am J Surg 192 2006 669 674
31. X. Lv, L. Yang, K. Tao, Y. Liu, T. Yang, and G. Chen Isoflurane preconditioning at clinically relevant doses induce protective effects of heme oxygenase-1 on hepatic ischemia reperfusion in rats BMC Gastroenterol 11 2011 31
32. N. Toda, H. Toda, and Y. Hatano Anesthetic modulation of immune reactions mediated by nitric oxide J Anesth 22 2008 155 162
33. K. Slankamenac, S. Breitenstein, B. Beck-Schimmer, R. Graf, M.A. Puhan, and P.A. Clavien Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery? HPB (Oxford) 14 2012 854 862
34. O. Scatton, S. Zalinski, D. Jegou, P. Compagnon, M. Lesurtel, and J. Belghiti Randomized clinical trial of ischaemic preconditioning in major liver resection with intermittent Pringle manoeuvre Br J Surg 98 2011 1236 1243
35. A. Winbladh, B. Bjornsson, L. Trulsson, K. Offenbartl, P. Gullstrand, and P. Sandstrom Ischemic preconditioning prior to intermittent Pringle maneuver in liver resections J Hepatobiliary Pancreat Sci 19 2012 159 170
36. V.B. Nieuwenhuijs, M.T. De Bruijn, R.T. Padbury, and G.J. Barritt Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage Dig Dis Sci 51 2006 1087 1102
37. R.S. Koti, J. Tsui, E. Lobos, W. Yang, A.M. Seifalian, and B.R. Davidson Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver FASEB J 19 2005 1155 1157
38. F. Serracino-Inglott, I.T. Virlos, N.A. Habib, R.C. Williamson, and R.T. Mathie Differential nitric oxide synthase expression during hepatic ischemia-reperfusion Am J Surg 185 2003 589 595
39. R. Varadarajan, L. Golden-Mason, L. Young, P. McLoughlin, N. Nolan, and G. McEntee Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation Transplantation 78 2004 250 256